is farxiga a glp 1 agonist GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Farxiga vs Ozempic: Pros, Cons

Here is what that looks like in practice

and 10% in the rest of the world are likely to be treated with GLP-1 therapies by 2035, up from approximately 6% in the U.S

Diabetes Obes Metab (2021) 23(9):21946

October 2025: Multiple studies have connected Mounjaro and other GLP-1 drugs with eye side effects and vision loss

Supporting your body's endogenous GLP-1 through dietary choices, physical activity, and lifestyle modifications offers a foundational approach to metabolic health

Initial concerns were raised by an early, methodologically critiqued study and a series of case reports in which the majority of severe ocular complications presented as NAION [114, 115]